View the historical price chart for CODX to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
No, CODX stock may not be the best buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether CODX stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
CODX presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 1618.8% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 4.14, and consider their own risk tolerance and investment timeline.
Based on our comprehensive analysis of CODX's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a HOLD. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
Analyze financial statements and market position
Review price charts and technical indicators
Evaluate market and company-specific risks
Healthcare
Medical Devices
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nuclei...
Make buy/hold/sell decision with price targets
Get detailed step-by-step analysis, risk assessment, and investment strategies
2401 S. Foothill Dr., Salt Lake City, UT 84109
United States
Get detailed executive information, governance metrics, and comprehensive corporate data